Skip to main content
Equibles

Quantinno Capital Management LP

Position in EBS — Emergent BioSolutions Inc.

CIK 1759654 NEW YORK, NY
Back to EBS Full portfolio

Position in EBS

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$375,784
+$248,819 QoQ
Shares Held
44,843
+193.1% QoQ
Ownership
0.087%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#79
of 194 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in EBS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Quantinno Capital Management LP holds $225,769,469 across 37 Drug Manufacturers - Specialty & Generic names. EBS ranks #31 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ELAN
Elanco Animal Health Inc
 1,974,908 $48,602,485
2 ZTS
Zoetis Inc.
 400,665 $28,791,786
3 TAK
Takeda Pharmaceutical Co Ltd
 1,402,650 $22,484,479
4 VTRS
Viatris Inc
 1,368,433 $21,730,716
5 UTHR
UNITED THERAPEUTICS Corp
 27,122 $14,695,513
6 PRGO
PERRIGO Co plc
 1,369,736 $14,231,557
7 NBIX
Neurocrine Biosciences Inc
 79,655 $13,425,053
8 HLN
Haleon plc
 1,151,189 $10,740,593

All Filings in EBS

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $375,784 44,843
2026-03-31 $126,965 15,297